Immunovant, Inc. IMVT Shares Reserved for Future Issuance Under Stock Plans
Shares Reserved for Future Issuance Under Stock Plans at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Immunovant, Inc.’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s shares reserved for future issuance under stock plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s shares reserved for future issuance under stock plans?
- Immunovant, Inc. (IMVT) reported shares reserved for future issuance under stock plans of 22.8M in Q4 2025.
- How has Immunovant, Inc.'s shares reserved for future issuance under stock plans changed year-over-year?
- Immunovant, Inc.'s shares reserved for future issuance under stock plans decreased by 2.6% year-over-year, from 23.5M to 22.8M.
- What is the long-term trend for Immunovant, Inc.'s shares reserved for future issuance under stock plans?
- Over 4 years (2021 to 2025), Immunovant, Inc.'s shares reserved for future issuance under stock plans has grown at a 20.7% compound annual growth rate (CAGR), from 10.9M to 23M.
- What does shares reserved for future issuance under stock plans mean?
- This represents the total number of common shares authorized and set aside for future issuance to employees and directors under equity compensation plans. It provides insight into the potential future dilution of existing shareholders. Investors monitor this to assess the firm's long-term incentive structure.